Insider Trading activities of Pharmacyclics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmacyclics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmacyclics Inc since year 2005. Table 2 shows the detailed insider transactions of Pharmacyclics Inc since 2005. The reporting company's ticker symbol is PCYC. The reporting company's CIK number is 949699.
The total value of stock buying since 2005 is $94,873,960.
The total value of stock sales since 2005 is $88,478,530.
The total value of stock option exercises since 2005 is $10,551,916.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pharmacyclics Inc (PCYC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-04 0 $0 0 $0 3,696 $99,976
2015-03 0 $0 57,514 $14,618,684 198,513 $2,447,822
2014-11 0 $0 40,982 $5,541,811 40,982 $263,999
2014-09 0 $0 12,000 $1,463,440 12,000 $27,599
2014-08 0 $0 49,562 $6,024,456 51,758 $2,409,255
2014-05 0 $0 0 $0 7,710 $199,997
2014-04 0 $0 0 $0 2,332 $133,297
2014-03 0 $0 65,535 $9,097,351 65,535 $989,345
2014-02 0 $0 78,835 $11,559,662 0 $0
2013-12 0 $0 99,000 $10,485,443 107,500 $960,852
2013-06 0 $0 18,750 $1,596,993 18,750 $571,125
2013-05 0 $0 77,716 $7,110,574 77,479 $1,114,119
2013-02 0 $0 32,000 $2,251,182 32,000 $65,519
2013-01 0 $0 42,645 $2,150,993 18,500 $90,005
2012-12 0 $0 233,925 $14,349,021 196,469 $388,813
2012-05 0 $0 18,565 $556,950 20,440 $166,178
2012-02 150,000 $3,128,100 23,941 $538,675 23,941 $61,288
2012-01 2,243,308 $38,928,091 0 $0 0 $0
2011-12 122,039 $1,879,886 18,125 $270,243 18,125 $114,966
2011-11 1,030,463 $13,681,075 0 $0 0 $0
2011-10 336,890 $3,900,848 0 $0 0 $0
2011-09 26,163 $308,409 0 $0 0 $0
2011-08 623,090 $6,209,090 0 $0 0 $0
2011-07 0 $0 0 $0 6,000 $4,500
2011-06 678,000 $6,000,300 0 $0 0 $0
2011-04 0 $0 0 $0 20,000 $15,000
2010-10 0 $0 61,630 $496,738 61,630 $91,619
2010-06 1,075,268 $6,999,994 0 $0 0 $0
2010-02 0 $0 0 $0 200,000 $182,000
2010-01 0 $0 87,879 $366,314 87,879 $123,143
2009-12 0 $0 0 $0 25,403 $31,499
2008-10 40,500 $82,134 0 $0 0 $0
2008-09 176,065 $434,880 0 $0 0 $0
2008-08 167,242 $267,587 0 $0 0 $0
2008-06 136,418 $238,537 0 $0 0 $0
2008-05 1,982,681 $2,081,815 0 $0 0 $0
2007-09 28,211 $72,210 0 $0 0 $0
2007-08 57,000 $118,663 0 $0 0 $0
2007-02 1,275,381 $3,834,202 0 $0 0 $0
2007-01 108,339 $531,077 0 $0 0 $0
2006-12 31,661 $155,202 0 $0 0 $0
2006-11 455,000 $2,175,300 0 $0 0 $0
2006-09 152,654 $709,854 0 $0 0 $0
2006-08 50,000 $215,650 0 $0 0 $0
2006-07 18,919 $67,692 0 $0 0 $0
2006-05 592,821 $2,353,857 0 $0 0 $0
2006-01 123,000 $499,507 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pharmacyclics Inc insiders (PCYC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-04-13 Tan Heow (Chief Quality&Tech Operations) Option Ex 3,696 27.05 99,976
2015-03-17 Tan Heow (Chief Quality&Tech Operations) Option Ex 3,696 27.05 99,976
2015-03-13 Soni Manmeet Singh (Chief Financial Officer) Sale 3,416 254.90 870,728
2015-03-12 Zanganeh Maky (Chief Operating Officer) Option Ex 140,719 1.52 214,596
2015-03-11 Soni Manmeet Singh (Chief Financial Officer) Sale 24,098 254.15 6,124,506
2015-03-11 Soni Manmeet Singh (Chief Financial Officer) Option Ex 24,098 79.57 1,917,550
2015-03-11 Zanganeh Maky (Chief Operating Officer) Sale 30,000 254.12 7,623,450
2015-03-11 Zanganeh Maky (Chief Operating Officer) Option Ex 30,000 7.19 215,700
2014-11-13 Soni Manmeet Singh (Chief Financial Officer) Sale 1,000 141.44 141,442
2014-11-13 Soni Manmeet Singh (Chief Financial Officer) Option Ex 1,000 61.60 61,600
2014-11-13 Fardis Maria (Chief of Oncology Ops & Allian) Sale 3,000 141.30 423,902
2014-11-13 Fardis Maria (Chief of Oncology Ops & Allian) Option Ex 3,000 6.84 20,520
2014-11-12 Zanganeh Maky (Chief Operating Officer) Sale 5,931 137.76 817,030
2014-11-12 Zanganeh Maky (Chief Operating Officer) Option Ex 5,931 7.19 42,643
2014-11-10 Love Richard B (General Counsel) Sale 1,500 133.87 200,805
2014-11-10 Love Richard B (General Counsel) Option Ex 1,500 32.38 48,570
2014-11-10 Zanganeh Maky (Chief Operating Officer) Sale 23,000 133.77 3,076,732
2014-11-10 Zanganeh Maky (Chief Operating Officer) Option Ex 23,000 2.30 52,899
2014-11-07 Fardis Maria (Chief of Oncology Ops & Allian) Sale 5,000 134.50 672,500
2014-11-07 Fardis Maria (Chief of Oncology Ops & Allian) Option Ex 5,000 6.84 34,200
2014-11-07 Zanganeh Maky (Chief Operating Officer) Sale 1,551 135.01 209,400
2014-11-07 Zanganeh Maky (Chief Operating Officer) Option Ex 1,551 2.30 3,567
2014-09-04 Zanganeh Maky (Chief Operating Officer) Sale 5,000 122.00 610,000
2014-09-04 Zanganeh Maky (Chief Operating Officer) Option Ex 5,000 2.30 11,500
2014-09-03 Zanganeh Maky (Chief Operating Officer) Sale 7,000 121.92 853,440
2014-09-03 Zanganeh Maky (Chief Operating Officer) Option Ex 7,000 2.30 16,099
2014-08-27 Love Richard B (General Counsel) Sale 1,500 124.00 186,000
2014-08-27 Love Richard B (General Counsel) Option Ex 1,500 32.38 48,570
2014-08-21 Tan Heow (Chief Quality&Tech Operations) Option Ex 2,196 27.05 59,401
2014-08-13 Fardis Maria (Chief of Oncology Ops & Allian) Sale 4,000 121.01 484,040
2014-08-13 Fardis Maria (Chief of Oncology Ops & Allian) Option Ex 4,000 6.84 27,360
2014-08-13 Tan Heow (Chief Quality&Tech Operations) Sale 10,000 123.58 1,235,810
2014-08-13 Tan Heow (Chief Quality&Tech Operations) Option Ex 10,000 27.05 270,500
2014-08-07 Mcgreivy Jesse (Chief Medical Officer) Sale 34,062 120.92 4,118,606
2014-08-07 Mcgreivy Jesse (Chief Medical Officer) Option Ex 34,062 58.82 2,003,424
2014-05-08 Sjovall Boultbee Paula S (EVP, Sales and Marketing) Option Ex 7,710 25.94 199,997
2014-04-29 Sjovall Boultbee Paula S (EVP, Sales and Marketing) Option Ex 2,332 57.16 133,297
2014-03-05 Fardis Maria (Chief of Oncology Ops & Allian) Sale 3,000 140.50 421,503
2014-03-05 Fardis Maria (Chief of Oncology Ops & Allian) Option Ex 3,000 6.84 20,520
2014-03-05 Mcgreivy Jesse (Chief Medical Officer) Sale 6,563 139.66 916,601
2014-03-05 Mcgreivy Jesse (Chief Medical Officer) Option Ex 6,563 25.33 166,240
2014-03-05 Sjovall Boultbee Paula S (EVP, Sales and Marketing) Sale 6,253 140.75 880,116
2014-03-05 Sjovall Boultbee Paula S (EVP, Sales and Marketing) Option Ex 6,253 25.94 162,202
2014-03-05 Hemmi Gregory (Sr. VP Chemical Operations) Sale 15,000 140.00 2,100,030
2014-03-05 Hemmi Gregory (Sr. VP Chemical Operations) Option Ex 15,000 .86 12,900
2014-03-04 Chang Betty Y (VP, Research/Biology) Sale 17,500 137.97 2,414,492
2014-03-04 Chang Betty Y (VP, Research/Biology) Option Ex 17,500 11.66 204,050
2014-03-04 Sjovall Boultbee Paula S (EVP, Sales and Marketing) Sale 13,747 137.07 1,884,328
2014-03-04 Sjovall Boultbee Paula S (EVP, Sales and Marketing) Option Ex 13,747 25.94 356,597
2014-03-04 Halvorson Eric H (Director) Sale 3,472 138.33 480,281
2014-03-04 Halvorson Eric H (Director) Option Ex 3,472 19.25 66,836
2014-02-27 Van Den Broek Richard (Director) Sale 25,000 144.92 3,622,999
2014-02-26 Van Den Broek Richard (Director) Sale 25,680 147.12 3,778,170
2014-02-25 Van Den Broek Richard (Director) Sale 28,155 147.70 4,158,493
2013-12-30 Hemmi Gregory (VP Chemical Operations) Option Ex 13,000 .75 9,750
2013-12-24 Tan Heow (Chief Quality&Tech Operations) Option Ex 1,500 27.05 40,575
2013-12-20 Smith David Duane (Director) Option Ex 1,000 1.92 1,920
2013-12-19 Tan Heow (Chief Quality&Tech Operations) Sale 5,000 100.86 504,275
2013-12-19 Tan Heow (Chief Quality&Tech Operations) Option Ex 5,000 27.05 135,250
2013-12-18 Hemmi Gregory (VP Chemical Operations) Sale 10,000 99.04 990,380
2013-12-18 Hemmi Gregory (VP Chemical Operations) Option Ex 10,000 .86 8,600
2013-12-17 Hemmi Gregory (VP Chemical Operations) Sale 10,000 102.00 1,020,000
2013-12-17 Hemmi Gregory (VP Chemical Operations) Option Ex 10,000 .86 8,600
2013-12-16 Zanganeh Maky (Chief Operating Officer) Sale 20,000 107.55 2,151,000
2013-12-16 Erdtmann Rainer M (Sr. VP, IR and Admin) Sale 22,835 107.72 2,459,672
2013-12-16 Erdtmann Rainer M (Sr. VP, IR and Admin) Option Ex 22,835 .91 20,779
2013-12-16 Smith David Duane (Director) Option Ex 13,000 54.39 707,018
2013-12-13 Erdtmann Rainer M (Sr. VP, IR and Admin) Sale 31,165 107.82 3,360,116
2013-12-13 Erdtmann Rainer M (Sr. VP, IR and Admin) Option Ex 31,165 .91 28,360
2013-06-06 Shearer Scott T (VP, Global Quality) Sale 18,750 85.17 1,596,993
2013-06-06 Shearer Scott T (VP, Global Quality) Option Ex 18,750 30.46 571,125
2013-05-31 Mcgreivy Jesse (VP, Clinical Science) Sale 14,479 91.13 1,319,514
2013-05-31 Mcgreivy Jesse (VP, Clinical Science) Option Ex 14,479 43.46 629,329
2013-05-31 Love Richard B (VP and General Counsel) Sale 8,000 89.00 712,000
2013-05-31 Love Richard B (VP and General Counsel) Option Ex 8,000 32.38 259,040
2013-05-31 Tan Heow (Chief of Technical Operations) Sale 5,237 91.84 480,960
2013-05-31 Tan Heow (Chief of Technical Operations) Option Ex 5,000 27.05 135,250
2013-05-31 Hemmi Gregory (VP Chemical Operations) Sale 50,000 91.96 4,598,100
2013-05-31 Hemmi Gregory (VP Chemical Operations) Option Ex 50,000 1.81 90,500
2013-02-11 Buggy Joseph J (VP, Research) Sale 12,000 69.97 839,663
2013-02-11 Buggy Joseph J (VP, Research) Option Ex 12,000 .86 10,320
2013-02-05 Loury David J (Chief Scientific Officer) Sale 20,000 70.58 1,411,519
2013-02-05 Loury David J (Chief Scientific Officer) Option Ex 20,000 2.76 55,199
2013-01-17 Mcgreivy Jesse (VP, Clinical Science) Sale 583 67.29 39,229
2013-01-11 Hemmi Gregory (VP Chemical Operations) Sale 5,000 67.11 335,550
2013-01-11 Hemmi Gregory (VP Chemical Operations) Option Ex 5,000 4.89 24,465
2013-01-09 Loury David J (Chief Scientific Officer) Sale 21,062 35.23 742,014
2013-01-08 Fardis Maria (EVP, Operations and Alliances) Sale 2,500 65.00 162,500
2013-01-08 Loury David J (Chief Scientific Officer) Sale 10,000 64.70 647,000
2013-01-08 Loury David J (Chief Scientific Officer) Option Ex 10,000 4.16 41,600
2013-01-07 Fardis Maria (EVP, Operations and Alliances) Sale 3,500 64.20 224,700
2013-01-07 Fardis Maria (EVP, Operations and Alliances) Option Ex 3,500 6.84 23,940
2012-12-31 Van Den Broek Richard (Director) Sale 7,171 58.50 419,474
2012-12-28 Van Den Broek Richard (Director) Sale 18,354 57.98 1,064,128
2012-12-27 Hemmi Gregory (VP Chemical Operations) Sale 12,900 59.50 767,550
2012-12-27 Hemmi Gregory (VP Chemical Operations) Option Ex 12,900 7.84 101,136
2012-12-27 Van Den Broek Richard (Director) Sale 11,931 58.02 692,236
2012-12-26 Hemmi Gregory (VP Chemical Operations) Sale 100 59.00 5,900
2012-12-26 Hemmi Gregory (VP Chemical Operations) Option Ex 100 4.47 447
2012-12-20 Loury David J (Chief Scientific Officer) Sale 39,469 61.12 2,412,266
2012-12-20 Loury David J (Chief Scientific Officer) Option Ex 39,469 4.16 164,191
2012-12-18 Erdtmann Rainer M (VP, IR Education Training) Sale 59,558 62.46 3,719,933
2012-12-18 Erdtmann Rainer M (VP, IR Education Training) Option Ex 59,558 .91 54,197
2012-12-17 Erdtmann Rainer M (VP, IR Education Training) Sale 34,442 62.73 2,160,684
2012-12-17 Erdtmann Rainer M (VP, IR Education Training) Option Ex 34,442 .91 31,342
2012-12-17 Buggy Joseph J (VP, Research) Sale 50,000 62.14 3,106,850
2012-12-17 Buggy Joseph J (VP, Research) Option Ex 50,000 .75 37,500
2012-05-17 Mehta Minesh (Director) Sale 18,565 30.00 556,950
2012-05-17 Mehta Minesh (Director) Option Ex 18,565 8.52 158,210
2012-05-08 Hemmi Gregory (VP Chemical Operations) Option Ex 1,875 4.25 7,968
2012-02-13 Mehta Minesh (Director) Sale 11,971 25.00 299,275
2012-02-13 Mehta Minesh (Director) Option Ex 11,971 2.56 30,645
2012-02-10 Baker Julian (10% Owner) Buy 150,000 20.85 3,128,100
2012-02-03 Mehta Minesh (Director) Sale 11,970 20.00 239,400
2012-02-03 Mehta Minesh (Director) Option Ex 11,970 2.56 30,643
2012-01-26 Baker Julian (10% Owner) Buy 291,967 17.92 5,232,631
2012-01-25 Baker Julian (10% Owner) Buy 150,362 18.49 2,780,191
2012-01-24 Baker Julian (10% Owner) Buy 157,261 17.93 2,820,003
2012-01-23 Baker Julian (10% Owner) Buy 194,697 16.87 3,284,927
2012-01-20 Baker Julian (10% Owner) Buy 297,858 16.42 4,891,523
2012-01-19 Baker Julian (10% Owner) Buy 41,855 15.98 668,925
2011-12-30 Hemmi Gregory (VP Chemical Operations) Sale 18,125 14.91 270,243
2011-12-30 Hemmi Gregory (VP Chemical Operations) Option Ex 18,125 6.34 114,966
2011-12-02 Baker Julian (10% Owner) Buy 105,118 15.40 1,619,236
2011-11-30 Baker Julian (10% Owner) Buy 76,166 14.92 1,136,548
2011-11-29 Baker Julian (10% Owner) Buy 194,525 14.19 2,759,919
2011-11-28 Baker Julian (10% Owner) Buy 179,823 13.35 2,400,456
2011-11-23 Baker Julian (10% Owner) Buy 97,082 12.76 1,238,765
2011-11-22 Baker Julian (10% Owner) Buy 85,403 12.69 1,083,506
2011-11-21 Baker Julian (10% Owner) Buy 74,381 12.13 902,464
2011-10-03 Baker Julian (10% Owner) Buy 170,000 11.58 1,968,429
2011-09-30 Baker Julian (10% Owner) Buy 26,163 11.79 308,409
2011-08-22 Baker Julian (10% Owner) Buy 331,400 9.96 3,302,400
2011-07-13 Hemmi Gregory (VP Chemical Operations) Option Ex 6,000 .75 4,500
2011-06-21 Duggan Robert W (Chairman & CEO) Buy 678,000 8.85 6,000,300
2011-04-28 Zanganeh Maky (Chief of Staff & VP Bus. Dev.) Option Ex 20,000 .75 15,000
2010-10-05 Hamdy Ahmed Md (Chief Medical Officer) Sale 15,000 8.20 122,999
2010-10-05 Hamdy Ahmed Md (Chief Medical Officer) Option Ex 15,000 .73 10,950
2010-10-01 Buggy Joseph J (VP, Research) Sale 46,630 8.02 373,739
2010-10-01 Buggy Joseph J (VP, Research) Option Ex 46,630 1.73 80,669
2010-06-21 Duggan Robert W (Chairman and CEO) Buy 1,075,268 6.51 6,999,994
2010-02-12 Rice Glenn C (Director) Option Ex 200,000 .91 182,000
2010-01-20 Bamdad Cynthia (Director) Sale 4,950 4.16 20,572
2010-01-20 Bamdad Cynthia (Director) Option Ex 4,950 1.94 9,603
2010-01-19 Bamdad Cynthia (Director) Sale 6,600 4.22 27,832
2010-01-19 Bamdad Cynthia (Director) Option Ex 6,600 1.62 10,725
2010-01-14 Bamdad Cynthia (Director) Sale 76,329 4.16 317,910
2010-01-14 Bamdad Cynthia (Director) Option Ex 76,329 1.35 102,815
2009-12-31 Adelman Jason T (Director) Option Ex 25,403 1.24 31,499
2008-10-01 Rice Glenn C (Director) Buy 40,500 2.03 82,134
2008-09-05 Duggan Robert W (Director) Buy 176,065 2.47 434,880
2008-08-22 Duggan Robert W (Director) Buy 1,200 1.60 1,920
2008-08-21 Duggan Robert W (Director) Buy 166,042 1.60 265,667
2008-06-26 Duggan Robert W (Director) Buy 16,300 1.71 27,873
2008-06-25 Duggan Robert W (Director) Buy 100 1.74 174
2008-06-24 Duggan Robert W (Director) Buy 38,000 1.87 71,060
2008-06-23 Duggan Robert W (Director) Buy 82,018 1.70 139,430
2008-05-30 Duggan Robert W (Director) Buy 1,982,681 1.05 2,081,815
2007-09-07 Duggan Robert W (10% Owner) Buy 20,433 2.55 52,104
2007-09-05 Duggan Robert W (10% Owner) Buy 7,778 2.58 20,106
2007-08-22 Miller Richard A Md (Pres, CEO & Director) Buy 5,000 2.00 10,000
2007-08-22 Lea Leiv (VP Fin & Admin & CFO) Buy 3,000 2.01 6,029
2007-08-21 Inouye Michael K (Sr. VP, Corp & Comm Dev.) Buy 20,000 2.04 40,740
2007-08-21 Miller Richard A Md (Pres, CEO & Director) Buy 5,000 2.00 10,005
2007-08-21 Lea Leiv (VP Fin & Admin & CFO) Buy 2,000 2.02 4,040
2007-08-14 Duggan Robert W (10% Owner) Buy 22,000 2.18 47,849
2007-02-21 Duggan Robert W (10% Owner) Buy 965,000 3.01 2,850,915
2007-01-03 Duggan Robert W (10% Owner) Buy 108,339 4.90 531,077
2006-12-29 Duggan Robert W (10% Owner) Buy 31,661 4.90 155,202
2006-11-08 Gilburne Miles R (Director) Buy 50,000 4.79 239,400
2006-11-08 Duggan Robert W (10% Owner) Buy 405,000 4.78 1,935,900
2006-09-20 Duggan Robert W (10% Owner) Buy 23,529 4.89 115,056
2006-09-19 Duggan Robert W (10% Owner) Buy 19,216 4.76 91,525
2006-09-18 Duggan Robert W (10% Owner) Buy 17,742 4.75 84,274
2006-09-08 Duggan Robert W (10% Owner) Buy 8,224 4.80 39,474
2006-09-07 Duggan Robert W (10% Owner) Buy 19,036 4.61 87,698
2006-09-06 Duggan Robert W (10% Owner) Buy 3,999 4.52 18,095
2006-09-05 Duggan Robert W (10% Owner) Buy 36,696 4.46 163,847
2006-09-01 Duggan Robert W (10% Owner) Buy 20,100 4.48 90,148
2006-08-31 Duggan Robert W (10% Owner) Buy 50,000 4.31 215,650
2006-07-13 Duggan Robert W (10% Owner) Buy 18,919 3.58 67,692
2006-05-22 Duggan Robert W (10% Owner) Buy 96,554 3.95 381,098
2006-05-19 Duggan Robert W (10% Owner) Buy 100,000 3.94 393,500
2006-05-18 Duggan Robert W (10% Owner) Buy 198,660 4.00 794,640
2006-01-10 Duggan Robert W (Director) Buy 80,300 4.18 335,413
2006-01-06 Duggan Robert W (Director) Buy 25,000 3.93 98,250
2006-01-05 Duggan Robert W (Director) Buy 17,700 3.72 65,844

Insider trading activities including stock purchases, stock sales, and option exercises of PCYC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmacyclics Inc (symbol PCYC, CIK number 949699) see the Securities and Exchange Commission (SEC) website.